Back to news
finance

Novanta Set to Expand Medical Offerings with Major Acquisition and Private Funding Round

Novanta Inc. (NASDAQ: NOVT) has announced plans to purchase Riverpoint Medical, significantly bolstering its presence in the medical technology sector. This strategic move is supported by a substantial private placement of equity to fund the acquisition, according to Seeking Alpha.

6/24/2026, 6:01:42 AM

Novanta Inc., a company specializing in advanced technology solutions, has unveiled its intention to acquire Riverpoint Medical. This significant transaction is valued at approximately $1.45 billion. The integration of Riverpoint Medical is expected to enhance Novanta's portfolio of medical products and services, particularly in areas like surgical illumination and medical intelligence. To facilitate this substantial acquisition, Novanta has simultaneously initiated a private offering of $300 million in convertible preferred stock. This private placement will help finance the costs associated with integrating Riverpoint Medical into Novanta's existing operations. The acquisition is a strategic step for Novanta as it seeks to expand its footprint and capabilities within the competitive medical technology market, as reported by Seeking Alpha. Riverpoint Medical is recognized for its innovative contributions to medical technology, offering a range of products that complement Novanta's current offerings. The combination of these two entities is anticipated to create a more robust platform for developing and delivering cutting-edge solutions to healthcare providers and patients globally. The leadership at Novanta views this acquisition as a pivotal moment for the company's growth trajectory. By bringing Riverpoint Medical under its umbrella, Novanta aims to leverage shared expertise and resources to accelerate innovation and market penetration. The financial aspects of the deal, including the private funding, underscore a confident outlook on the synergistic potential between the two companies. Looking ahead, the successful integration of Riverpoint Medical is expected to lead to enhanced product development, broader market reach, and increased value for shareholders. The company's focus remains on delivering advanced technology that addresses critical needs in medical and industrial applications, and this acquisition represents a substantial stride in that direction.

Share